Concepts (96)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Blood Banks | 1 | 2017 | 535 | 0.44 | Why? |
| Referral and Consultation | 1 | 2017 | 4816 | 0.22 | Why? |
| ADP-ribosyl Cyclase 1 | 1 | 2018 | 96 | 0.19 | Why? |
| Fees and Charges | 1 | 2017 | 27 | 0.18 | Why? |
| Physicians | 1 | 2017 | 4214 | 0.17 | Why? |
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2021 | 449 | 0.17 | Why? |
| Interleukin-1beta | 1 | 2020 | 992 | 0.14 | Why? |
| Interleukin-8 | 1 | 2020 | 964 | 0.14 | Why? |
| Erythrocytes | 1 | 2018 | 617 | 0.12 | Why? |
| Blood Transfusion | 2 | 2020 | 1399 | 0.12 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2020 | 2483 | 0.10 | Why? |
| Diagnostic Tests, Routine | 1 | 2021 | 2643 | 0.10 | Why? |
| Multiple Myeloma | 1 | 2018 | 1064 | 0.09 | Why? |
| Epidemiological Monitoring | 1 | 2020 | 3493 | 0.08 | Why? |
| Neutralization Tests | 1 | 2021 | 6698 | 0.08 | Why? |
| Liver Regeneration | 1 | 2004 | 38 | 0.07 | Why? |
| Antibodies, Viral | 4 | 2021 | 51949 | 0.07 | Why? |
| Saliva | 1 | 2021 | 4679 | 0.07 | Why? |
| Antibodies, Neutralizing | 2 | 2021 | 25288 | 0.06 | Why? |
| New York City | 3 | 2021 | 7432 | 0.06 | Why? |
| Antineoplastic Agents | 1 | 2018 | 3550 | 0.06 | Why? |
| Interleukin-6 | 1 | 2020 | 7522 | 0.06 | Why? |
| Pulmonary Embolism | 1 | 2021 | 4775 | 0.06 | Why? |
| Hepatocytes | 1 | 2004 | 549 | 0.06 | Why? |
| Hepatitis, Autoimmune | 1 | 2004 | 254 | 0.05 | Why? |
| Immunization, Passive | 3 | 2021 | 10067 | 0.05 | Why? |
| Antibodies, Monoclonal | 1 | 2018 | 8041 | 0.05 | Why? |
| Coombs Test | 1 | 2018 | 66 | 0.05 | Why? |
| Stem Cells | 1 | 2004 | 595 | 0.05 | Why? |
| Transfusion Reaction | 1 | 2020 | 245 | 0.04 | Why? |
| Blood Grouping and Crossmatching | 1 | 2018 | 125 | 0.04 | Why? |
| Hepatitis B, Chronic | 1 | 2004 | 616 | 0.04 | Why? |
| Benchmarking | 1 | 2021 | 627 | 0.04 | Why? |
| Critical Care | 1 | 2020 | 14081 | 0.04 | Why? |
| Hospital Mortality | 1 | 2020 | 22087 | 0.04 | Why? |
| Hepatitis C, Chronic | 1 | 2004 | 973 | 0.04 | Why? |
| Enzyme-Linked Immunosorbent Assay | 2 | 2021 | 7868 | 0.04 | Why? |
| RNA, Viral | 1 | 2021 | 32276 | 0.03 | Why? |
| Spike Glycoprotein, Coronavirus | 2 | 2020 | 37182 | 0.03 | Why? |
| Limit of Detection | 1 | 2021 | 2698 | 0.03 | Why? |
| Hospitalization | 2 | 2020 | 54280 | 0.03 | Why? |
| Diagnostic Errors | 1 | 2018 | 865 | 0.03 | Why? |
| Lung | 1 | 2021 | 31049 | 0.03 | Why? |
| Propensity Score | 1 | 2020 | 2690 | 0.03 | Why? |
| Urban Population | 1 | 2020 | 2000 | 0.03 | Why? |
| United States | 1 | 2017 | 46150 | 0.03 | Why? |
| Humans | 12 | 2021 | 930598 | 0.02 | Why? |
| Inflammation Mediators | 1 | 2021 | 2654 | 0.02 | Why? |
| Autopsy | 1 | 2021 | 3495 | 0.02 | Why? |
| Middle Aged | 7 | 2021 | 270681 | 0.02 | Why? |
| Cytokines | 2 | 2021 | 15010 | 0.02 | Why? |
| Aged | 6 | 2021 | 215776 | 0.02 | Why? |
| Blood Coagulation | 1 | 2021 | 2768 | 0.02 | Why? |
| Lymphocytes | 1 | 2020 | 3056 | 0.02 | Why? |
| Cause of Death | 1 | 2021 | 4823 | 0.02 | Why? |
| Male | 7 | 2021 | 367725 | 0.02 | Why? |
| Female | 7 | 2021 | 380317 | 0.02 | Why? |
| Keratin-7 | 1 | 2004 | 4 | 0.02 | Why? |
| S Phase | 1 | 2004 | 12 | 0.02 | Why? |
| Survival Rate | 1 | 2020 | 9206 | 0.02 | Why? |
| Keratins | 1 | 2004 | 33 | 0.02 | Why? |
| Cell Division | 1 | 2004 | 136 | 0.02 | Why? |
| Bile Ducts | 1 | 2004 | 84 | 0.02 | Why? |
| Retrospective Studies | 3 | 2020 | 105322 | 0.02 | Why? |
| Fibrin Fibrinogen Degradation Products | 1 | 2020 | 5993 | 0.02 | Why? |
| C-Reactive Protein | 1 | 2020 | 7972 | 0.02 | Why? |
| Adult | 5 | 2021 | 244371 | 0.02 | Why? |
| Specimen Handling | 1 | 2021 | 6190 | 0.02 | Why? |
| Ambulatory Care | 1 | 2020 | 4947 | 0.02 | Why? |
| Aged, 80 and over | 3 | 2021 | 88759 | 0.02 | Why? |
| Severity of Illness Index | 2 | 2020 | 48226 | 0.01 | Why? |
| Adolescent | 3 | 2020 | 86841 | 0.01 | Why? |
| Protein Binding | 1 | 2018 | 11430 | 0.01 | Why? |
| Nasopharynx | 1 | 2021 | 10224 | 0.01 | Why? |
| Infant | 2 | 2020 | 30274 | 0.01 | Why? |
| Case-Control Studies | 1 | 2020 | 17671 | 0.01 | Why? |
| Hospitals | 1 | 2020 | 11793 | 0.01 | Why? |
| Host-Pathogen Interactions | 1 | 2021 | 11041 | 0.01 | Why? |
| Child, Preschool | 2 | 2020 | 36283 | 0.01 | Why? |
| Young Adult | 2 | 2020 | 93724 | 0.01 | Why? |
| Infant, Newborn | 1 | 2020 | 23105 | 0.01 | Why? |
| DNA | 1 | 2004 | 778 | 0.01 | Why? |
| Pandemics | 3 | 2020 | 389249 | 0.01 | Why? |
| Incidence | 1 | 2020 | 25622 | 0.01 | Why? |
| Time Factors | 1 | 2020 | 31397 | 0.01 | Why? |
| Immunohistochemistry | 1 | 2004 | 2275 | 0.01 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.01 | Why? |
| Child | 2 | 2020 | 70012 | 0.01 | Why? |
| Practice Guidelines as Topic | 1 | 2018 | 15421 | 0.01 | Why? |
| Treatment Outcome | 1 | 2020 | 51732 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2020 | 53120 | 0.01 | Why? |
| Pneumonia, Viral | 1 | 2020 | 243684 | 0.01 | Why? |
| Coronavirus Infections | 1 | 2020 | 253789 | 0.01 | Why? |
| Risk Factors | 1 | 2020 | 71621 | 0.01 | Why? |
| Liver | 1 | 2004 | 4007 | 0.01 | Why? |
| Betacoronavirus | 1 | 2020 | 204454 | 0.00 | Why? |
Jhang's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(96)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(221)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_